1. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload
- Author
-
Rui Adão, Catherine Rucker-Martin, David Montani, P. Mendes-Ferreira, Mélanie Lambert, Valérie Domergue, Véronique Capuano, Rozenn Quarck, Maria-Rosa Ghigna, Frédéric Perros, Jean-Luc Vachiery, Hélène Leribeuz, Angèle Boet, Carmen Brás-Silva, Marc Humbert, Fabrice Antigny, Quarck, Rozenn, Hôpital Bicêtre, Adhésion et Inflammation (LAI), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Chirurgical Marie Lannelongue (CCML), Universidade do Porto = University of Porto, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), University Hospitals Leuven [Leuven], Institut Paris Saclay d’Innovation Thérapeutique (IPSIT), Université Paris-Sud - Paris 11 (UP11)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université Paris-Saclay, Cliniques Universitaires de Bruxelles [Bruxelles, Belgique], Antigny, Fabrice, and ANR-18-CE14-0023,KAPAH,KCNK3 une nouvelle cible thérapeutique dans l'hypertension artérielle pulmonaire(2018)
- Subjects
MESH: Signal Transduction ,0301 basic medicine ,Physiology ,[SDV]Life Sciences [q-bio] ,Proliferation ,030204 cardiovascular system & hematology ,K2P3.1 ,MESH: Ventricular Function, Left ,Ventricular Function, Left ,Muscle hypertrophy ,Ventricular Dysfunction, Left ,0302 clinical medicine ,Fibrosis ,MESH: Ventricular Dysfunction, Left ,MESH: Animals ,MESH: Nerve Tissue Proteins ,Pulmonary Arterial Hypertension ,Ascending-aortic constriction ,MESH: Potassium Channels, Tandem Pore Domain ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,Ventricular pressure ,Cardiology ,Rats, Transgenic ,Cardiology and Cardiovascular Medicine ,MESH: Vascular Remodeling ,Signal Transduction ,MESH: Pulmonary Arterial Hypertension ,medicine.medical_specialty ,MESH: Mutation ,MESH: Arterial Pressure ,MESH: Pulmonary Artery ,Concentric hypertrophy ,Nerve Tissue Proteins ,Pulmonary Artery ,Vascular Remodeling ,03 medical and health sciences ,Potassium Channels, Tandem Pore Domain ,Physiology (medical) ,Internal medicine ,medicine.artery ,Ventricular Pressure ,medicine ,Animals ,Arterial Pressure ,MESH: Ventricular Pressure ,Lung ,business.industry ,Task-1 ,medicine.disease ,Pulmonary hypertension ,PH due to left heart diseases ,Disease Models, Animal ,030104 developmental biology ,Ventricle ,MESH: Rats, Transgenic ,Mutation ,Pulmonary artery ,MESH: Disease Models, Animal ,business - Abstract
Aims Pulmonary hypertension (PH) is a common complication of left heart disease (LHD, Group 2 PH) leading to right ventricular (RV) failure and death. Several loss-of-function (LOF) mutations in KCNK3 were identified in pulmonary arterial hypertension (PAH, Group 1 PH). Additionally, we found that KCNK3 dysfunction is a hallmark of PAH at pulmonary vascular and RV levels. However, the role of KCNK3 in the pathobiology of PH due to LHD is unknown. Methods and results We evaluated the role of KCNK3 on PH induced by ascending aortic constriction (AAC), in WT and Kcnk3-LOF-mutated rats, by echocardiography, RV catheterization, histology analyses, and molecular biology experiments. We found that Kcnk3-LOF-mutation had no consequence on the development of left ventricular (LV) compensated concentric hypertrophy in AAC, while left atrial emptying fraction was impaired in AAC-Kcnk3-mutated rats. AAC-animals (WT and Kcnk3-mutated rats) developed PH secondary to AAC and Kcnk3-mutated rats developed more severe PH than WT. AAC-Kcnk3-mutated rats developed RV and LV fibrosis in association with an increase of Col1a1 mRNA in right ventricle and left ventricle. AAC-Kcnk3-mutated rats developed severe pulmonary vascular (pulmonary artery as well as pulmonary veins) remodelling with intense peri-vascular and peri-bronchial inflammation, perivascular oedema, alveolar wall thickening, and exaggerated lung vascular cell proliferation compared to AAC-WT-rats. Finally, in lung, right ventricle, left ventricle, and left atrium of AAC-Kcnk3-mutated rats, we found a strong increased expression of Il-6 and periostin expression and a reduction of lung Ctnnd1 mRNA (coding for p120 catenin), contributing to the exaggerated pulmonary and heart remodelling and pulmonary vascular oedema in AAC-Kcnk3-mutated rats. Conclusions Our results indicate that Kcnk3-LOF is a key event in the pathobiology of PH due to AAC, suggesting that Kcnk3 channel dysfunction could play a potential key role in the development of PH due to LHD.
- Published
- 2021